VMQ StocksFor the value investor looking to harness academic research in
an actively managed portfolio
Bits and BipsNewsletter delivering insights on linking traditional finance, macro trends and cryptocurrency opportunities to help investors build stronger, more diversified portfolios.
All premium products come with free basic membership.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Learn more about whether Guardian Pharmacy Services, Inc. or NeoGenomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether agilon health, inc. or Guardian Pharmacy Services, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Aveanna Healthcare Holdings Inc. or Guardian Pharmacy Services, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
As of Friday, June 26, Guardian Pharmacy Services, Inc.’s GRDN share price has surged by
5.03%, which has investors questioning if this is right time to sell.
As of Tuesday, June 23, Guardian Pharmacy Services, Inc.’s GRDN share price has dipped by
5.13%, which has investors questioning if this is right time to buy.
Cynthia McLaughlin
Financial Summary
Share Statistics
GRDN
Industry Median
Percentile (All Stocks)
Market Cap (Mil)
$2,608.8
$1,875.0
57%
Shares Out (Mil)
63.7
77.1
54%
Institutional Ownership
73.2%
88.9%
44%
Float (Mil)
32.0
50.3
38%
Beta
na
0.86
na
Avg Daily Volume (000s)
290
466
50%
Price Change (52-week)
102.7%
78.5%
92%
Growth
GRDN
Industry Median
Percentile (All Stocks)
Sales (5yr)
14.5%
10.9%
72%
Net Income (5yr)
19.8%
(1.1%)
73%
EPS (5yr)
na
3.0%
na
Dividends (5yr)
0.0%
0.0%
0%
Cash Flow (5yr)
na
(18.2%)
na
Estimates
Qtrly
Current Fiscal Year
Next Fiscal Year
# of Estimates
6
6
6
Current EPS
$0.262
$1.260
$1.358
Month Ago EPS
$0.262
$1.260
$1.358
# Rev Up
2
2
3
# Rev Down
0
0
0
Three Months Ago EPS
$0.263
$1.225
$1.348
Year/Year Chg
25.4%
62.0%
93.7%
Financials
GRDN
Industry Median
Percentile (All Stocks)
Sales (TTM) (Mil)
$1,456
$1,464
56%
Net Income (TTM) (Mil)
$53
$15
56%
EPS (TTM)
$0.846
$0.300
59%
Operating Cash Flow (TTM) (Mil)
$89
$138
52%
Net Cash Flow (TTM) (Mil)
$51
$7
71%
Long-Term Debt (Q1) (Mil)
$34
$323
36%
Enterprise Value (Q1) (Mil)
$2,424
$2,130
52%
Valuation
GRDN
Industry Median
Percentile (All Stocks)
P/B
11.81
2.90
91%
P/E
49.3
26.8
83%
Dividend Yield
0.0%
0.0%
0%
PEG (5yr hist)
na
1.1
na
Ratios
GRDN
Industry Median
Percentile (All Stocks)
Gross Margin
20.9%
27.6%
22%
Net Margin
3.6%
1.1%
44%
ROA
13.9%
1.8%
93%
ROE
28.2%
6.9%
86%
Liabilities to Assets
45.6%
60.0%
37%
F-Score
5
5
51%
Guardian Pharmacy Services, Inc. did not pass any screens on 7/30/2026.
Looking for access to this powerful feature? Take the first step in becoming an A+ Investor today.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors